WHO Releases Updated Guidelines To Improve Treatment Of Drug-Resistant TB, Accelerate Progress To End Disease

IDSA’s “Science Speaks”: WHO finalizes MDR-TB treatment guidance recommending shift from injections
“…[T]he World Health Organization [Wednesday] released updated guidelines for treating TB that does not respond to first-line treatments. … The guidelines are part of a larger plan aiming to speed access to successful treatment for tuberculosis worldwide…” (Barton, 3/20).

VOA News: WHO: New Oral Treatment More Effective in Combating Multidrug-Resistant TB
“…In advance of this year’s World TB Day, March 24, the World Health Organization is issuing a call to action to eradicate the disease by 2030. As part of these efforts, the WHO is launching an oral drug regimen it says can more effectively treat people with multi-drug resistant tuberculosis. … The WHO says it is hopeful the new oral treatment program it is launching will be more effective in controlling the spread of the particularly virulent form of tuberculosis…” (Schlein, 3/20).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.